Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Bayer HealthCare AG

Home Clinical Trial Sponsors and OrganizationsBayer HealthCare AG

Bayer HealthCare AG

ACTIVE

Germanywww.bayerhealthcare.comPrivate10,001+ employees

Part of BAYER AG

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

897

879 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

423

47.2%

Phase 3

11

1.2%

Not Applicable

6

0.7%

Phase 4

2

0.2%

Phase 2

1

0.1%

Trial Status Distribution

Active, not recruiting

879

98.0%

Completed

14

1.6%

Recruiting

2

0.2%

Clinical Trials

Trials sponsored by this organization (897)

Phase 2/3 study of rogaratinib (pan FGFR inhibitor) vs chemotherapy in patients with locally advanced or metastatic urothelial carcinoma with a high amount of specific cell growth factor receptors 1 and 3 (FGFR1 and 3) in the tumor cells

Active, not recruiting

Sep 20191,627 participants

Multiple escalating dose study of BAY 1093884 in adults with hemophilia A or B with or without inhibitors

Active, not recruiting

Aug 201924 participants

Assess safety and efficacy of vilaprisan in subjects with endometriosis

Active, not recruiting

Dec 20188 participants

A study to test whether study drug BAY1128688 brings pain relief towomen with endometriosis and if so to get a first idea which dose(s) workbest.

Active, not recruiting

Aug 2018121 participants

A study to compare rivaroxaban, following successful TAVR, to an antiplatelet drug and determine if it is superior in reducing death or first thromboembolic events (DTE) and non-inferior towards primary bleeding events (PBE).

Active, not recruiting

Aug 20181,644 participants

Rivaroxaban for treatment of venous or arterial blood clots in children frombirth to less than 6 months

Active, not recruiting

Mar 20188 participants

A study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.

Active, not recruiting

Feb 2018700 participants

Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine Fibroids

Active, not recruiting

Feb 2018996 participants

Page 1 of 113

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials897
Approvals
News

Back to Organizations